Compare EHang Holdings Ltd - ADR (EH) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Merck & Co., Inc. — how do they compare? EHang Holdings Ltd - ADR trades at $5.48 (market cap $414.87M), while Merck & Co., Inc. trades at $126.42 (market cap $305.29B). The key difference: Merck & Co., Inc. is far larger — about 735.9× EHang Holdings Ltd - ADR's market cap, and Merck & Co., Inc. pays a 2.75% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | MRK | |
|---|---|---|
Market Cap | $414.87M | $305.29B |
Sector | Industrials | Health |
52-Week High | $19.99 | $129.52 |
52-Week Low | $5.41 | $77.60 |
Enterprise Value | $354.54M | $348.71B |
Dividend Yield | — | 2.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
